Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 42.

Steinman, L; Bar-Or, A; Behne, J M; Benitez-Ribas, D; Chin, P S; Clare-Salzler, M; Healey, D; Kim, J I; Kranz, D M; Lutterotti, A; Martin, R; Schippling, S; Villoslada, P; Wei, C H; Weiner, H L; Zamvil, S S; Yeaman, M R; Smith, T J (2016). Restoring immune tolerance in neuromyelitis optica: Part I. Neurology: Neuroimmunology and Neuroinflammation, 3(5):e276.

Bar-Or, A; Steinman, L; Behne, J M; Benitez-Ribas, D; Chin, P S; Clare-Salzler, M; Healey, D; Kim, J I; Kranz, D M; Lutterotti, A; Martin, R; Schippling, S; Villoslada, P; Wei, C H; Weiner, H L; Zamvil, S S; Smith, T J; Yeaman, M R (2016). Restoring immune tolerance in neuromyelitis optica: Part II. Neurology: Neuroimmunology and Neuroinflammation, 3(5):e277.

Kappos, L; Edan, G; Freedman, M S; Montalbán, X; Hartung, H P; Hemmer, B; Fox, E J; Barkhof, F; Schippling, S; Schulze, A; Pleimes, D; Pohl, C; Sandbrink, R; Suarez, G; Wicklein, E M (2016). The 11-year long-term follow-up study from the randomized BENEFIT CIS trial. Neurology, 87(10):978-987.

Schippling, S; O'Connor, P; Knappertz, V; Pohl, C; Bogumil, T; Suarez, G; Cook, S; Filippi, M; Hartung, H P; Comi, G; Jeffery, D R; Kappos, L; Goodin, D S; Arnason, B (2016). Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial. Journal of Neurology, 263(7):1418-1426.

Ziemssen, T; Derfuss, T; de Stefano, N; Giovannoni, G; Palavra, F; Tomic, D; Vollmer, T; Schippling, S (2016). Optimizing treatment success in multiple sclerosis. Journal of Neurology, 263(6):1053-1065.

Opfer, R; Suppa, P; Kepp, T; Spies, L; Schippling, S; Huppertz, H J (2016). Atlas based brain volumetry: How to distinguish regional volume changes due to biological or physiological effects from inherent noise of the methodology. Magnetic Resonance Imaging, 34(4):455-461.

Martinez-Lapiscina, Elena H; Arnow, Sam; Wilson, James A; et al; Schippling, S (2016). Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurology, 15(6):574-84.

Hanson, J V; Lukas, S C; Pless, M; Schippling, S (2016). Optical Coherence Tomography in Multiple Sclerosis. Seminars in Neurology, 36(2):177-184.

von Gumberz, J; Mahmoudi, M; Young, K; Schippling, S; Martin, R; Heesen, C; Siemonsen, S; Stellmann, J P (2016). Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting. PeerJ, 4:e2442.

Grigoriadis, N; van Pesch, V; Schippling, S (2015). A basic overview of multiple sclerosis immunopathology. European Journal of Neurology, 22(S2):3-13.

Oreja-Guevara, C; Schippling, S (2015). Overview of magnetic resonance imaging for management of relapsing-remitting multiple sclerosis in everyday practice. European Journal of Neurology, 22(S2):22-27.

Gallo, P; Schippling, S; Van Wijmeersch, B (2015). Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations. European Journal of Neurology, 22(Supp.2):14-21.

Lysandropoulos, A P; Havrdová, E; Schippling, S (2015). ‘Hidden’ factors influencing quality of life in patients with multiple sclerosis. European Journal of Neurology, 22(Supp.2):28-33.

Ray, U; Cinque, P; Gerevini, S; Longo, V; Lazzarin, A; Schippling, S; Martin, R; Buck, C B; Pastrana, D V (2015). JC polyomavirus mutants escape antibody-mediated neutralization. Science Translational Medicine, 7(306):306ra151.

Schippling, S; Balk, Lj; Costello, F; Albrecht, P; Balcer, L; Calabresi, Pa; Frederiksen, Jl; Frohman, E; Green, Aj; Klistorner, A; Outteryck, O; Paul, F; Plant, Gt; Traber, G; Vermersch, P; Villoslada, P; Wolf, S; Petzold, A (2015). Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria. Multiple Sclerosis, 21(2):163-170.

Bennett, J L; de Seze, J; Lana-Peixoto, M; Palace, J; Waldman, A; Schippling, S; Tenembaum, S; Banwell, B; Greenberg, B; Levy, M; Fujihara, K; Chan, K H; Kim, H J; Asgari, N; Sato, D K; Saiz, A; Wuerfel, J; Zimmermann, H; Green, A; Villoslada, P; Paul, F (2015). Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography. Multiple Sclerosis, 21(6):678-688.

Petzold, A; Wattjes, M P; Costello, F; Flores-Rivera, J; Fraser, C L; Fujihara, K; Leavitt, J; Marignier, R; Paul, F; Schippling, S; Sindic, C; Villoslada, P; Weinshenker, B; Plant, G T (2014). The investigation of acute optic neuritis: a review and proposed protocol. Nature Reviews. Neurology, 10(8):447-58.

Neuromyelitis Optica Study Group (NEMOS); Metz, I; Ringelstein, M; Ruprecht, K; et al; Schippling, S (2014). Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. Multiple Sclerosis, 20(7):882-888.

Oberwahrenbrock, T; Ringelstein, M; Jentschke, S; Deuschle, K; Klumbies, K; Bellmann-Strobl, J; Harmel, J; Ruprecht, K; Schippling, S; Hartung, H; Aktas, O; Brandt, A U; Paul, F (2013). Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome. Multiple Sclerosis, 19(14):1887-1895.

Trebst, C; Jarius, S; Berthele, A; Paul, F; Schippling, S; Wildemann, B; Borisow, N; Kleiter, I; Aktas, O; Kümpfel, T (2013). Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS). Journal of Neurology:online.

Lutterotti, A; Yousef, S; Sputtek, A; Stürner, K H; Stellmann, J P; Breiden, P; Reinhardt, S; Schulze, C; Bester, M; Heesen, Ch; Schippling, S; Miller, S D; Sospedra, M; Martin, R (2013). Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis. Science Translational Medicine, 5(188):188ra75.

Rieckmann, P; Boyko, A; Centonze, D; Coles, A; Elovaara, I; Havrdová, E; Hommes, O; Lelorier, J; Morrow, S A; Oreja-Guevara, C; Rijke, N; Schippling, S (2013). Future MS care: a consensus statement of the MS in the 21st Century Steering Group. Journal of Neurology, 260(2):462-469.

Tillack, K; Naegele, M; Haueis, C; Schippling, S; Wandinger, K P; Martin, R; Sospedra, M (2013). Gender differences in circulating levels of neutrophil extracellular traps in serum of multiple sclerosis patients. Journal of Neuroimmunology, 261(1-2):108-119.

Schippling, S; Kempf, C; Büchele, F; Jelcic, I; Bozinov, O; Bont, A; Linnebank, M; Sospedra, M; Weller, M; Budka, H; Martin, R (2013). JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment. Annals of Neurology, 74(4):622-626.

Young, K L; Brandt, A U; Petzold, A; Reitz, L Y; Lintze, F; Paul, F; Martin, R; Schippling, S (2013). Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis. European Journal of Neurology, 20(5):803-811.

Zimmermann, H; Freing, A; Kaufhold, F; Gaede, G; Bohn, E; Bock, M; Oberwahrenbrock, T; Young, K L; Dörrie, J; Wuerfel, J T; Schippling, S; Paul, F; Brandt, A U (2013). Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Multiple sclerosis (Houndmills, Basingstoke, England), 19(4):443-450.

Stellmann, J P; Neuhaus, A; Herich, L; Schippling, S; Roeckel, M; Daumer, M; Martin, R; Heesen, C (2012). Placebo cohorts in phase-3 MS treatment trials - predictors for on-trial disease activity 1990-2010 based on a meta-analysis and individual case data. PLoS ONE, 7(11):e50347.

Schippling, S (2012). Optische Kohärenztomographie. In: Schmidt, R; Hoffmann, F; Faiss, J H; Köhler, W. Multiple Sklerose. München: Elsevier, 4-13.

Schippling, S (2012). Stammzelltransplantation bei Multipler Sklerose. In: Schmidt, R; Hoffmann, F; Faiss, J H; Köhler, W. Multiple Sklerose. München: Elsevier, 353-359.

Jarius, S; Ruprecht, K; Wildemann, B; Kuempfel, T; Ringelstein, M; Geiser, C; Kleiter, I; Kleinschnitz, C; Berthele, A; Brettschneider, J; Hellwig, K; Hemmer, B; Linker, R A; Lauda, F; Mayer, C A; Tumani, H; Melms, A; Trebst, C; Stangel, M; Marziniak, M; Hoffmann, F; Schippling, S; Faiss, J H; Neuhaus, O; Ettrich, B; Zentner, C; Guthke, K; Hofstadt-van Oy, U; Reuss, R; Pellkofer, H; Ziemann, U; Kern, P; Wandinger, K P; Bergh, F; Boettcher, T; Langel, S; Liebetrau, M; Rommer, P S; Niehaus, S; Münch, C; Winkelmann, A; Zettl U, U K; Metz, I; Veauthier, C; Sieb, J P; Wilke, C; Hartung, H P; Aktas, O; Paul, F (2012). Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients. Journal of Neuroinflammation, 9:14.

Reder, A T; Schippling, S (2012). Impact of treatment on long-term survival in MS: Summary of results from interferon beta-1b 21-year long-term follow-up study. International Journal of MS Care, 14(Sup 4):11-16.

Planas, R; Jelčić, I; Schippling, S; Martin, R; Sospedra, M (2012). Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis. European Journal of Immunology, 42(3):790-798.

Naegele, M; Tillack, K; Reinhardt, S; Schippling, S; Martin, R; Sospedra, M (2012). Neutrophils in multiple sclerosis are characterized by a primed phenotype. Journal of Neuroimmunology, 242(1-2):60-71.

Lutterotti, A; Jelcic, I; Schulze, C; Schippling, S; Breiden, P; Mazzanti, B; Reinhardt, S; DiGioia, M; Repice, A; Massacesi, L; Sputtek, A; Salinas-Riester, G; Kroeger, N; Sospedra, M; Saccardi, R; Zander, A; Martin, R (2012). No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients. Multiple Sclerosis Journal, 18(8):1188-1192.

Metz, I; Radue, E W; Oterino, A; Kümpfel, T; Wiendl, H; Schippling, S; Kuhle, J; Sahraian, M A; Gray, F; Jakl, V; Häusler, D; Brück, W (2012). Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathologica, 123(2):235-245.

Brandt, A U; Zimmermann, H; Kaufhold, F; Promesberger, J; Schippling, S; Finis, D; Aktas, O; Geiser, C; Ringelstein, M; Ringelstein, E B; Hartung, H P; Paul, F; Kleffner, I; Dörr, J (2012). Patterns of retinal damage facilitate differential diagnosis between Susac syndrome and MS. PLoS ONE, 7(6):e38741.

Reitz, L Y; Inglese, M; Fiehler, J; Finsterbusch, J; Holst, B; Heesen, C; Martin, R; Schippling, S (2012). Quantitative T2' imaging in patients with clinically isolated syndrome. Acta Neurologica Scandinavica, 126(5):357-363.

Oberwahrenbrock, T; Schippling, S; Ringelstein, M; Kaufhold, F; Zimmermann, H; Keser, N; Young, K L; Harmel, J; Hartung, H P; Martin, R; Paul, F; Aktas, O; Brandt, A U (2012). Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography. Multiple sclerosis international, 2012:530305.

Schippling, S; Martin, R (2012). Stammzelltransplantation bei multipler Sklerose. In: Schmidt, R M; Hoffmann, F A. Multiple Sklerose. München: Elsevier, Urban, 67-71.

Tewarie, P; Balk, L; Costello, F; Green, A; Martin, R; Schippling, S; Petzold, A (2012). The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS ONE, 7(4):e34823.

Aly, L; Yousefi, S; Schippling, S; Jelcic, I; Breiden, P; Matschke, J; Schulz, R; Bofill-Mas, S; Jones, L; Demina, V; Linnebank, M; Ogg, G; Girones, R; Weber, T; Sospedra, M; Martin, R (2011). Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. Brain: A Journal of Neurology, 134(Pt 9):2687-2702.

Brandt, A U; Oberwahrenbrock, T; Ringelstein, M; Young, K L; Tiede, M; Hartung, H P; Martin, R; Aktas, O; Paul, F; Schippling, S (2011). Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain: A Journal of Neurology, 134(Pt 11):e193; author reply e194.

This list was generated on Mon Jun 17 10:58:13 2019 CEST.